What Has Been the Growth of the Enteral Feeding Formula Market So Far?
The enteral feeding formula market has seen considerable growth due to a variety of factors.
• The market size for enteral feeding formula has seen robust growth in the past few years. The market is projected to increase from $6.53 billion in 2024 to $7.16 billion in 2025, with a compound annual growth rate (CAGR) of 9.6%.
This growth during the historic period is associated with factors such as an aging population, a rise in chronic diseases, technological innovations in enteral feeding formula, growing recognition of clinical nutrition, and expansion of home healthcare services.
What Are the Future Growth Projections for the Enteral Feeding Formula Market?
The enteral feeding formula market is expected to maintain its strong growth trajectory in upcoming years.
• The market size for enteral feeding formulas is projected to witness swift expansion in the coming years, reaching an estimation of $10.67 billion in 2029 with a compound annual growth rate (CAGR) of 10.5%.
The growth can be tracked down to several factors such as the increasing cases of malnutrition, a rising elderly population, advancements in enteral nutrition studies, the growing use of at-home enteral nutrition, and an increase in the numbers of hospitals and long-term care facilities. Significant trends expected throughout this period include the creation of enteral feeding formulas specific to various diseases, an increased demand for plant-based and organic formulas, a focus on immunonutrition in enteral feeding, customised enteral nutrition solutions, and the adoption of blenderized tube feeding formulas.
Which Factors Are Boosting Growth In The Enteral Feeding Formula Market?
The expansion of the enteral feeding formula market is likely to be fueled by the increasing elderly population. Around the world, there has been a noticeable rise in the population of individuals who are 65 years or older. This segment of the populace is typically more susceptible to chronic illnesses, and as a result, often necessitates enteral nourishment. Therefore, the surge in the elderly population correlates with a heightened demand for enteral feeds. As an example, the World Health Organization, an international public health institution based in Switzerland, predicted in October 2022 that the world population of people aged 60 years and over would grow to 1.4 billion by 2022, up from 1 billion in 2020. Additionally, by 2030, every sixth individual in the world will be over 60 years old. As a result of this burgeoning elderly population, the enteral feeding formula market is expected to grow exponentially.
What Key Areas Define The Segmentation Of The Global Enteral Feeding Formula Market?
The enteral feeding formula market covered in this report is segmented –
1) By Product: Standard Formulas, Disease-Specific Formulas
2) By Stage: Adults, Pediatrics
3) By Application: Oncology, Gastroenterology, Neurology, Diabetes, Critical Care, Other Applications
4) By End User: Hospitals, Long-Term Care Facilities
Subsegments:
1) By Standard Formulas: Polymer-Based Formulas, Oligomeric Formulas, High-Protein Formulas
2) By Disease-Specific Formulas: Diabetic Formulas, Renal Formulas, Pulmonary Formulas, Oncology Formulas
Pre-Book The Enteral Feeding Formula Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
How Are Emerging Trends Reshaping The Dynamics Of The Enteral Feeding Formula Market?
One prevailing trend in the enteral feeding formula market is the emphasis on product innovation. Companies within the sector are continually creating and debuting novel enteral formulas. The introduction of such products offers consumers a range of choices and leads to an increased demand, thereby boosting the market for enteral feeding formulas. Take for example the healthcare services company based in the U.S., Cardinal Health, Inc., who introduced the Kangaroo OMNI Enteral Feeding Pump in September 2023. This ground-breaking device is tailored to meet patients' varying needs during their enteral feeding course. As the first of its kind in the U.S that can dispense thick, homogenized and mixed formulas, the Kangaroo OMNI promises to revolutionize enteral feeding systems. Due to its compact and mobile design, it offers a variety of feeding, flushing, and hydration options, and can even record a 30-day feeding history. The Kangaroo OMNI represents a comprehensive solution to fulfill patients' and caregivers' enteral feeding needs, whether in a hospital or at home.
Who Are the Key Players in the Enteral Feeding Formula Market?
Major companies operating in the enteral feeding formula market include:
• Abbott Laboratories
• Nestlé S. A.
• Danone S. A.
• Fresenius Kabi AG
• B. Braun Melsungen AG
• Meiji Holdings Co. Ltd.
• Real Food Blends
• Ajinomoto Cambrooke Inc.
• Otsuka Pharmaceutical Co. Ltd.
• Medtrition Inc.
• Nutri-Force Nutrition
• Global Health Product Inc.
• VICTUS
• Primus Pharmaceuticals Inc.
• Kate Farms
• Baxter International Inc.
• Perrigo Nutritionals LLC
• Reckitt Benckiser Group plc
• Bio-Serv Inc.
• Nutrabalace Ltd.
• ProSynbiotics
• Med-Diet Laboratories Inc.
• Precision Foods-kent corporation
• SimplyThick LLC
• Coram LLC
• Vitaflow LLC
What Is The Most Dominant Region In The Enteral Feeding Formula Market?
North America was the largest region in the enteral feeding formula market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the enteral feeding formula market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
